Laszlo Kiss - CBO and Head of Research @ Gilgamesh Pharmaceuticals

Overview

CB Rank (Investor)

Laszlo Kiss is the CBO and Head of Research at Gilgamesh Pharmaceuticals. He attended University of California, San Diego.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Triplet Therapeutics	Pfizer Venture Investments	Yes	Series A - Triplet Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Magnolia NeuroSciences	Pfizer Venture Investments	—	Series A - Magnolia NeuroSciences	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

CBO and Head of Research

. Additionally,

has had

past job as the

Executive Director, WRD and Principal at Pfizer Ventures

Organization Name	Title At Company	Start Date	End Date
Pfizer	Executive Director, WRD and Principal at Pfizer Ventures	Jul 2016	Jun 2020

Hub Name	CB Rank (Hub)
Mental Health Companies With Fewer Than 1000 Employees (Top 10K)	9,878
Mental Health Startups	46,233
Prime Movers Lab Portfolio Companies	62,265
National Institute on Drug Abuse (NIDA) Portfolio Companies	95,596
East Coast Health Care Companies with Early Stage Venture Funding	64,910
Northeastern US Biotechnology Companies with Early Stage Venture Funding	71,196
Pioneer Fund Portfolio Companies	47,498
Medical Early Stage Companies With Fewer Than 1000 Employees	29,925
Biotechnology Early Stage Companies With Fewer Than 50 Employees	26,245
East Coast Mental Health Companies	17,129

studied at

There is no recent news or activity for this profile.